Reach the top with Paragon Genomics!
Paragon Genomics received its Quality Management System ISO 9001:2015 certificate on August 26, 2020. Click to view the certificate.
Paragon Genomics specializes in target enrichment and library preparation for next-generation sequencing (NGS). We develop and commercialize best-in-class reagents, protocols, and molecular diagnostic tools that break the limits of conventional target enrichment technologies. Our proprietary primer design and library preparation technologies enable us to design and create ultra-high multiplexed NGS panels with exceptional ease-of-use, sensitivity, and performance that cannot be addressed with conventional technologies. Our reagents have enabled customers to analyze low-input and challenging samples, such as FFPE DNA from tumor samples and cell-free DNA from liquid biopsies, and allowed customers to rapidly evolve and scale up the content of their assays. Our products are designed in-house and manufactured California. These novel reagents can be developed for specified sample types and applications and are available through our Custom and OEM Solutions Program. We invite you to join the growing number of leading academic, pharmaceutical, life sciences, genetic testing, and diagnostic institutions who have incorporated our reagents to advance their translational research and assay development projects and differentiate their product offerings.
- Founded in 2015
- Headquartered in the San Francisco Bay Area – one of the largest biotech hubs in the world
- R&D and manufacturing facility in Hayward, CA
- Reagents protected by issued and pending patents
- Custom amplicon-based NGS panel design and optimization
- NGS-based assay development and validation
- Customized kit configuration and packaging
For Research Use Only. Not for use in diagnostic procedures.
For more information, please contact us to learn more about how we could accelerate your assay design and development.